CDK6 and bladder transitional cell carcinoma: Based on these results, we hypothesized that CDK6 was associated with cancer progression from the NMIBC to MIBC stage and approximately one-fourth of BLCA cases (23% in TCGA database and 29% in GSE13507 cohort), displayed high CDK6 transcriptional levels correlated with reduced survival.